Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : AQIM-I
Catalog No.: PC-21551Not For Human Use, Lab Use Only.
AQIM-I is a highly potent small molecule survivin inhibitor by targeting ILF3/NF110, binds to ILF3/NF110 with KD value of 163 nM in SPR assays, has broad-spectrum antitumor activity.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
AQIM-I is a highly potent small molecule survivin inhibitor by targeting ILF3/NF110, binds to ILF3/NF110 with KD value of 163 nM in SPR assays, has broad-spectrum antitumor activity.
AQIM-I exhibits high antiproliferation potency and excellent selectivity with IC50 values of 0.009 and 21.5 μM against A549 and L929, respectively.
AQIM-I exhibits potent activity against MCF-7 and TE-1, with IC50 values of 0.06 and 0.05 μM, respectively, and considerable potency against H460 (IC50 = 0.14 μM), 5637 (IC50 = 0.18 μM), HepG2 (IC50 = 0.25 μM), H1299 (IC50 = 0.51 μM), and 143B (IC50 = 0.59 μM).
AQIM-I predominantly shows significant antiproliferative activity against cancer cells and low toxicity against normal cells.
AQIM-I produces ROS and causes DNA damage in A549 cells, induces the cell cycle G0/G1 phase arrest, induces apoptosis and autophagy of A549 cells.
AQIM-I attenuates the enhanced survivin promoter activity induced by the overexpression of ILF3/NF110.
AQIM-I (2 mg/kg) markedly inhibits tumor growth in vivo and exhibits greater safety than YM155 and DOX.
| M.Wt | 404.21 | |
| Formula | C17H13IN2O2 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Yuan J, et al. J Med Chem. 2023 Dec 11. doi: 10.1021/acs.jmedchem.3c01551.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
